Page last updated: 2024-11-03

risperidone and Bulimia

risperidone has been researched along with Bulimia in 2 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Bulimia: Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as ox hunger.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Theleritis, CG1
Papadimitriou, GN1
Papageorgiou, CC1
Dikeos, DG1
Masdrakis, V1
Kostoulas, C1
Psarros, C1
Soldatos, CR1
Crockford, DN1
Fisher, G1
Barker, P1

Other Studies

2 other studies available for risperidone and Bulimia

ArticleYear
Excessive weight gain after remission of depression in a schizophrenic patient treated with risperidone: case report.
    BMC psychiatry, 2006, Sep-05, Volume: 6

    Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bulimia; Depression; Diabetes

2006
Risperidone, weight gain, and bulimia nervosa.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1997, Volume: 42, Issue:3

    Topics: Antipsychotic Agents; Bulimia; Child; Dose-Response Relationship, Drug; Female; Humans; Risk Factors

1997